CLN5 allelic variation in Alzheimer’s disease and the common pathologies of lysosome dysfunction in many other neurodegenerative diseases mean that future focus on CLN5 will likely drive our understanding of brain function more widely. The gene discussed is CLN5; the disease is early-onset autosomal dominant Alzheimer disease.